Kabanov awarded funding from Eshelman Institute for Innovation
On June 1, the Eshelman Institute for Innovation (EII) awarded $3.5 million across 24 projects to support research and education at the UNC Eshelman School of Pharmacy. Alexander “Sasha” Kabanov’s “Targeting of inflamed monocytes for gene therapy of cancer” was … Read more